Epidemiology of Parkinson's diseaseTANNER, C. M.Neurologic clinics. 1992, Vol 10, Num 2, pp 317-329, issn 0733-8619Article

Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortiumMCGUIRE, V; VAN DEN EEDEN, S. K; TOPOL, B et al.Journal of the neurological sciences. 2011, Vol 307, Num 1-2, pp 22-29, issn 0022-510X, 8 p.Article

Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson diseasePOPAT, R. A; VAN DEN EEDEN, S. K; TANNER, C. M et al.Neurology. 2005, Vol 65, Num 3, pp 383-390, issn 0028-3878, 8 p.Article

Midlife adiposity and the future risk of Parkinson's diseaseABBOTT, R. D; ROSS, G. W; WHITE, L. R et al.Neurology. 2002, Vol 59, Num 7, pp 1051-1057, issn 0028-3878Article

Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's diseaseCHAN, P; JIANG, X; FORNO, L. S et al.Neurology. 1998, Vol 50, Num 4, pp 1136-1137, issn 0028-3878Article

CYP2D6 allelic frequencies in young-onset Parkinson's diseaseSANDY, M. S; ARMSTRONG, M; TANNER, C. M et al.Neurology. 1996, Vol 47, Num 1, pp 225-230, issn 0028-3878Article

Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with on-off fluctuationsKURTH, M. C; TETRUD, J. W; TANNER, C. M et al.Neurology. 1993, Vol 43, Num 9, pp 1698-1703, issn 0028-3878Article

Dopaminergic agonists in the treatment of Parkinson's disease. DiscussionGOETZ, C. G; KLAWANS, H. L; OLANOW, C. W et al.Neurology. 1990, Vol 40, Num 10, pp 50-57, issn 0028-3878, 8 p., Suppl. 3Article

The genetics of Parkinson's disease : a reconsideration. DiscussionGOLBE, L. I; OLANOW, C. W; TANNER, C. M et al.Neurology. 1990, Vol 40, Num 10, pp 7-16, issn 0028-3878, 10 p., Suppl. 3Article

Excessive daytime sleepiness and subsequent development of Parkinson diseaseABBOTT, R. D; ROSS, G. W; WHITE, L. R et al.Neurology. 2005, Vol 65, Num 9, pp 1442-1446, issn 0028-3878, 5 p.Article

Occupation and parkinsonism in three movement disorders clinicsGOLDMAN, S. M; TANNER, C. M; OLANOW, C. W et al.Neurology. 2005, Vol 65, Num 9, pp 1430-1435, issn 0028-3878, 6 p.Article

Early dopaminergic drug-induced hallucinations in parkinsonian patientsGOETZ, C. G; VOGEL, C; TANNER, C. M et al.Neurology. 1998, Vol 51, Num 3, pp 811-814, issn 0028-3878Article

Failure to find the α-synuclein gene missense mutation (G²⁰⁹A) in 100 patients with younger onset Parkinson's diseasePIU CHAN; TANNER, C. M; XIN JIANG et al.Neurology. 1998, Vol 50, Num 2, pp 513-514, issn 0028-3878Article

Aluminium neurotoxicity : a reevaluationMURRAY, J. C; TANNER, C. M; SPRAGUE, S. M et al.Clinical neuropharmacology. 1991, Vol 14, Num 2, pp 179-185, issn 0362-5664, 7 p.Article

Abnormal liver enzyme-mediated metabolism in Parkinson's disease : a second lookTANNER, C. M; KURLAND, DR; JOHNSON, DR et al.Neurology. 1991, Vol 41, Num 5, pp 89-92, issn 0028-3878, 4 p., SUP2Conference Paper

Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor dataGOETZ, C. G; TANNER, C. M; PENN, R. D et al.Neurology. 1990, Vol 40, Num 2, pp 273-276, issn 0028-3878Article

Predicting Parkinson's disease. DiscussionLANGSTON, J. W; GOETZ, C. G; KLAWANS, H. L et al.Neurology. 1990, Vol 40, Num 10, pp 70-76, issn 0028-3878, 7 p., Suppl. 3Article

Development and progression of motor fluctuations and side effects in Parkinson's disease : comparison of Sinemet CR versus carbidopa/levodopaGOETZ, C.G; TANNER, C. M; GILLEY, D. W et al.Neurology. 1990, Vol 39, Num 11, pp 63-66, issn 0028-3878, 4 p., SUPLT2Conference Paper

Hypersexuality with antiparkinsonian therapyUITTI, R. J; TANNER, C. M; RAJPUT, A. H et al.Clinical neuropharmacology. 1989, Vol 12, Num 5, pp 375-383, issn 0362-5664Article

Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's diseaseGOETZ, C. G; OLANOW, C. W; COMELLA, C. L et al.The New England journal of medicine. 1989, Vol 320, Num 6, pp 337-341, issn 0028-4793Article

Relationship of aluminium to neurocognitive dysfunction in chronic dialysis patientsSPRAGUE, S. M; CORWIN, H. L; TANNER, C. M et al.Archives of internal medicine (1960). 1988, Vol 148, Num 10, pp 2169-2172, issn 0003-9926Article

The autonomic nervous system in Gilles de la Tourette's syndromeGOETZ, C. G; SHANNON, K. M; CARROLL, V. S et al.Movement disorders. 1987, Vol 2, Num 2, pp 99-102, issn 0885-3185Article

Encephalopathy in chronic renal failure responsive to deferoxamine therapy: another manifestation of aluminium neurotoxicitySPRAGUE, S. M; CORWIN, H. L; WILSON, R. S et al.Archives of internal medicine (1960). 1986, Vol 146, Num 10, pp 2063-2064, issn 0003-9926Article

Can discography cause long-term back symptoms in previously asymptomatic subjects?CARRAGEE, E. J; YUNG CHEN; TANNER, C. M et al.Spine (Philadelphia, PA. 1976). 2000, Vol 25, Num 14, pp 1803-1808, issn 0362-2436Article

Impact of Alzheimer's-type dementia and information source on the assessment of depressionGILLEY, D. W; WILSON, R. S; FLEISCHMAN, D. A et al.Psychological assessment. 1995, Vol 7, Num 1, pp 42-48, issn 1040-3590Article